Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,516.27 98.74 0.68%
TOPIX 1,173.37 6.78 0.58%
HANG SENG 22,760.24 64.23 0.28%

UPCOMING DEADLINE: Levi & Korsinsky, LLP Notifies Investors of Class Action Against Biolase, Inc. and Its Board of Directors and

  UPCOMING DEADLINE: Levi & Korsinsky, LLP Notifies Investors of Class Action
  Against Biolase, Inc. and Its Board of Directors and a Lead Plaintiff
  Deadline of October 22, 2013 -- BIOL

Business Wire

NEW YORK -- October 18, 2013

Levi & Korsinsky announces that a class action lawsuit has been commenced in
the United States District Court for the Central District of California on
behalf of investors who purchased Biolase, Inc. (“Biolase” or the “Company”)
(NasdaqCM:BIOL) stock between January 7, 2013 and August 12, 2013.

For more information, click here:

The complaint alleges that during the Class Period, defendants failed to
disclose and/or concealed that: (a) there is little evidence demonstrating
that the use of dental lasers provides long-term benefits to teeth; (b)
Biolase's efforts to switch to a direct sales model in the United States were
failing; (c) the debt burden the Company assumed to exit its arrangement with
the former exclusive distributor of its WaterLase products, coupled with the
terms of certain of its Comerica lines of credit, were financially
handicapping the Company; and (d) there was no cash being generated from
operations and the Company was in default of its Comerica lines of credit.

On August 7, 2013, Biolase announced its second quarter 2013 financial
results, reporting revenues of just $14.2 million. Then on August 13, 2013,
the Company announced that it was in violation of its bank covenants.

If you suffered a loss in Biolase you have until October 22, 2013 to request
that the Court appoint you as lead plaintiff. Your ability to share in any
recovery doesn’t require that you serve as a lead plaintiff. To obtain
additional information, contact Joseph E. Levi, Esq. either via email at or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or

Levi & Korsinsky is a national firm with offices in New York, New Jersey,
Connecticut, and Washington D.C. The firm has extensive expertise in
prosecuting securities litigation involving financial fraud, representing
investors throughout the nation in securities and shareholder lawsuits.
Attorney advertising. Prior results do not guarantee similar outcomes.


Levi & Korsinsky, LLP
Joseph Levi, Esq.
Eduard Korsinsky, Esq.
Tel: 212-363-7500
Toll Free: 877-363-5972
Fax: 212-363-7171
Sponsored Links
Sponsored Links